Johnson & Johnson’s fourth-quarter medical device sales fell by 4.7%, to $6.6 billion, with the biggest drop (7.7%) in the U.S., the company announced this week. Total fourth-quarter sales were down 0.6% year-over-year, to $18.3 ...
Tags: Medical Device Business, Health
The common stock of healthcare and medical device giant Johnson & Johnson (JNJ) soared to recent highs following the company's announcement of first quarter results that beat analysts' estimates. The company's robust performance was ...
Tags: Health, Medicine, medical device
Biosense Webster has obtained an approval from the US Food and Drug Administration (FDA) for its Thermocool Smarttouch catheter that enables direct and real-time measurement of contact force during catheter ablation procedures for patients ...
Tags: FDA Approval, Biosense Webster
CardioFocus, developer of the HeartLight endoscopic ablation system (EAS) for the treatment of atrial fibrillation (AF), has concluded enrollment of its US pivotal trial evaluating the HeartLight system, for the treatment of symptomatic ...
Coherex Medical, a developer of medical devices, has obtained CE Mark approval for its Coherex WaveCrest left atrial appendage (LAA) occlusion system. WaveCrest LAA Occluder seals off the LAA opening so that blood clots cannot escape into ...
Tags: Coherex Medical, CE Mark
Johnson & Johnson (J&J) Innovation has opened the new California Innovation Center to build early stage collaborations with emerging companies in science and technology and advance healthcare. The new centre has the flexibility to adapt ...
Tags: Health, Medicine, healthcare
Sidroc Services, a company specialized in promoting and distributing medical equipments, has entered into an agreement to distribute BioElectronics' products in European country Malta. The products for distribution include BioElectronics' ...
Tags: BioElectronics, Sidroc, Distribution Deal
CardioFocus will complete full patient enrollment in a US pivotal clinical trial of its HeartLight catheter ablation system in 2013. The 350 patient-based trial, which is evaluating and comparing the safety and efficacy of the company's ...